The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKγ

Structure

Volumn 12, Issue 9, 2004, Pages 1719-1728

  Saito, Kohei ^a   Kigawa, Takanori ^a   Koshiba, Seizo ^a   Sato, Kazuo ^a,b   Matsuo, Yo ^a,b   Sakamoto, Ayako ^a   Takagi, Tetsuo ^a   Shirouzu, Mikako ^a,c   Yabuki, Takashi ^a   Nunokawa, Emi ^a   Seki, Eiko ^a   Matsuda, Takayoshi ^a   Aoki, Masaaki ^a   Miyata, Yukako ^a   Hirakawa, Noriko ^a   Inoue, Makoto ^a   Terada, Takaho ^a,c   Nagase, Takahiro ^d   Kikuno, Reiko ^d   Nakayama, Manabu ^d   Ohara, Osamu ^d,e   Tanaka, Akiko ^a   Yokoyama, Shigeyuki ^a,c,f   more..

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c RIKEN HARIMA INSTITUTE   (Japan)

^d KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^e RIKEN   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYLD PROTEIN; GLYCINE DERIVATIVE; I KAPPA B KINASE GAMMA; IKKGAMMA PROTEIN; PROLINE DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CYTOSKELETON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; HELA CELLS; HUMANS; I-KAPPA B KINASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROLINE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ALIGNMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 4444349272     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2004.07.012     Document Type: Article

References (56)

1. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830
2. Biggs P.J., Wooster R., Ford D., Chapman P., Mangion J., Quirk Y., Easton D.F., Burn J., Stratton M.R. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13. evidence for its role as a tumour suppressor gene Nat. Genet. 11:1995;441-443
3. Biggs P.J., Chapman P., Lakhani S.R., Burn J., Stratton M.R. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene. 12:1996;1375-1377
4. Bignell G.R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P.J., Lakhani S.R., et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25:2000;160-165
5. Bradley J.R., Pober J.S. Tumor necrosis factor receptor-assoicated factors (TRAFs). Oncogene. 20:2001;6482-6491
6. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature. 424:2003;797-801
7. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
8. Cesareni G., Panni S., Nardelli G., Castagnoli L. Can we infer peptide recognition specificity mediated by SH3 domains? FEBS Lett. 513:2002;38-44
9. Chen G., Cao P., Goeddel D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell. 9:2002;401-410
10. Clore G.M., Gronenborn A.M. Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol. 239:1994;349-363
11. Cornilescu G., Delaglio F., Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR. 13:1999;289-302
12. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:2000;351-361
13. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., Bodemer C., Kenwrick S., Dupuis-Girod S., Blanche S., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27:2001;277-285
14. Feierbach B., Nogales E., Downing K.H., Stearns T. Alf1p, a CLIP-170 domain-containing protein, is functionally and physically associated with α-tubulin. J. Cell Biol. 144:1999;113-124
15. Freund C., Kuhne R., Yang H., Park S., Reinherz E.L., Wagner G. Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules. EMBO J. 21:2002;5986-5995
16. Ghose R., Shekhtman A., Goger M.J., Ji H., Cowburn D. A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nat. Struct. Biol. 8:2001;998-1004
17. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109:2002;S81-S96
18. Hu M., Li P., Li M., Li W., Yao T., Wu J.W., Gu W., Cohen R.E., Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 111:2002;1041-1054
19. Huang X., Poy F., Zhang R., Joachimiak A., Sudol M., Eck M.J. Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat. Struct. Biol. 7:2000;634-638
20. Huang T.T., Feinberg S.L., Suryanarayanan S., Miyamoto S. The zinc finger domain of NEMO is selectively required for NF-κB activation by UV radiation and topoisomerase inhibitors. Mol. Cell. Biol. 22:2002;5813-5825
21. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell. 115:2003;565-576
22. Jain A., Ma C.A., Liu S., Brown M., Cohen J., Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2:2001;223-228
23. Kami K., Takeya R., Sumimoto H., Kohda D. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p. EMBO J. 21:2002;4268-4276
24. Kigawa T., Yabuki T., Yoshida Y., Tsutsui M., Ito Y., Shibata T., Yokoyama S. Cell-free production and stable-isotope labeling of milligram quantities of proteins. FEBS Lett. 442:1999;15-19
25. Kigawa T., Yabuki T., Matsuda N., Matsuda T., Nakajima R., Tanaka A., Yokoyama S. Preparation of Escherichia coli cell extract for highly productive cell-free protein expression. J. Struct. Funct. Genomics. 5:2004;63-68
26. Kikuno R., Nagase T., Waki M., Ohara O. Huge. a database for human large proteins identified in the kazusa cDNA sequencing project Nucleic Acids Res. 30:2002;166-168
27. Koradi R., Billeter M., Wuthrich K. Momol. a program for display and analysis of macromolecular structures J. Mol. Graph. 14:1996;51-55
28. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature. 424:2003;801-805
29. Li S., Finley J., Liu Z.J., Qiu S.H., Chen H., Luan C.H., Carson M., Tsao J., Johnson D., Lin G., et al. Crystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain. J. Biol. Chem. 277:2002;48596-48601
30. Macias M.J., Wiesner S., Sudol M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513:2002;30-37
31. Makris C., Godfrey V.L., Krahn-Senftleben G., Takahashi T., Roberts J.L., Schwarz T., Feng L., Johnson R.S., Karin M. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell. 5:2000;969-979
32. Makris C., Roberts J.L., Karin M. The carboxyl-terminal region of IκB kinase γ (IKKγ) is required for full IKK activation. Mol. Cell. Biol. 22:2002;6573-6581
33. McWhirter S.M., Pullen S.S., Holton J.M., Crute J.J., Kehry M.R., Alber T. Crystrallographic analysis of CD40 recognition and signaling by human TRAF2. Proc. Natl. Acad. Sci. USA. 96:1999;8408-8413
34. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and and empirical binding free energy function. J. Comp. Chem. 19:1998;1639-1662
35. Ni C.Z., Welsh K., Leo E., Chiou C.K., Wu H., Reed J.C., Ely K.R. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. USA. 97:2000;10395-10399
36. Park Y.C., Burkitt V., Villa A.R., Tong L., Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature. 398:1999;533-538
37. Pierre P., Pepperkok R., Kreis T.E. Molecular characterization of two functional domains of CLIP-170 in vivo. J. Cell Sci. 107:1994;1909-1920
38. Powers R., Garrett D.S., March C.J., Frieden E.A., Gronenborn A.M., Clore G.M. The high-resolution, three-dimensional solution structure of human Interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry. 32:1993;6744-6762
39. Prehoda K.E., Lee D.J., Lim W.A. Structure of the enabled/VASP homology 1 domain-peptide complex. a key component in the spatial control of actin assembly Cell. 97:1999;471-480
40. Radcliffe P.A., Toda T. Characterisation of fission yeast alp11 mutants defines three functional domains within tubulin-folding cofactor B. Mol. Gen. Genet. 263:2000;752-760
41. Riehemann K., Sorg C. Sequence homologies between four cytoskeleton-associated proteins. Trends Biochem. Sci. 18:1993;82-83
42. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKKγ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300
43. Rudolph D., Yeh W.C., Wakeham A., Rudolph B., Nallainathan D., Potter J., Elia A.J., Mak T.W. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14:2000;854-862
44. Scheel J., Pierre P., Rickard J.E., Diamantopoulos G.S., Valetti C., van der Goot F.G., Haner M., Aebi U., Kreis T.E. Purification and analysis of authentic CLIP-170 and recombinant fragments. J. Biol. Chem. 274:1999;25883-25891
45. Schmidt-Supprian M., Bloch W., Courtois G., Addicks K., Israel A., Rajewsky K., Pasparakis M. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell. 5:2000;981-992
46. Shi C.S., Kehrl J.H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278:2003;15429-15434
47. Smahi A., Courtois G., Vabres P., Yamaoka S., Heuertz S., Munnich A., Israel A., Heiss N.S., Klauck S.M., Kioschis P., et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 405:2000;466-472
48. Takahashi M., Rapley E., Biggs P.J., Lakhani S.R., Cooke D., Hansen J., Blair E., Hofmann B., Siebert R., Turner G., et al. Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13. Hum. Genet. 106:2000;58-65
49. Tang E.D., Wang C.Y., Xiong Y., Guan K.L. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J. Biol. Chem. 278:2003;37297-37305
50. Thomson S.A., Rasmussen S.A., Zhang J., Wallace M.R. A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16. Hum. Genet. 105:1999;171-173
51. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature. 424:2003;793-796
52. Uren A.G., Vaux D.L. TRAF proteins and meprins share a conserved domain. Trends Biochem. Sci. 21:1996;244-245
53. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351
54. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240
55. Ye H., Park Y.C., Kreishman M., Kieff E., Wu H. The structure basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell. 4:1999;321-330
56. Zhou H., Wertz I., O'Rourke K., Ultsch M., Seshagiri S., Eby M., Xiao W., Dixit V.M. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature. 427:2004;167-171